Lexology July 18, 2024
The U.S. House of Representatives and the U.S. Senate are advancing a new bill the BIOSECURE Act (H.R. 8333i and S. 3558ii) that would (i) prohibit the U.S. Government from contracting with “biotechnology companies of concern”iii and (ii) prohibit U.S. life sciences companies with federal government contracts or that receive federal funding from collaborating with such designated companies. The BIOSECURE Act attempts to counter perceived national security threats posed by Chinese biotechnology companies who could exploit information about American citizens through joint research and utilization of biotechnology equipment or services.
House and Senate committees have voted favorably on the bill with overwhelming bipartisan support. As of this writing, however, the bill has not been debated on the floor of either...
Today's Sponsors
Today's Sponsor